CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01905475
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 120 participants
- Sponsor
- Polyphor Ltd.
- Registry
-
NCT01905475
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Austria, Germany, Hungary, Poland, United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT01905475. Randomized; quadruple masking; primary purpose treatment. Start 2013-07 (registry gives no type); primary completion 2015-10 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- CXCR4 Antagonism for Cell Mobilisation and Healing in Acute Myocardial Infarction (CATCH-AMI)
- Acronym
- CATCH-AMI
- Condition
- Large Reperfused ST-Elevation Myocardial Infarction
- Intervention (Drug)
- POL6326
- Intervention (Drug)
- Placebo
- Lead sponsor
- Polyphor Ltd.
Record details
- Record id
cardio:ct-nct01905475- Content hash
9a41d1b67be2adf7ee2360b666b020fcced54c459a7aec4f5f6278ca80fe9543